-
Product Insights
ABC Jodhpur Solar PV Park
ABC Jodhpur Solar PV Park is a solar PV project located in Rajasthan, India. The project is owned by Axis Energy Ventures India Pvt Ltd; Brookfield Renewable Corp and was developed by ABC Renewable Energy Pvt Ltd. The project came online in 2022. Empower your strategies with our ABC Jodhpur Solar PV Park report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to...
-
Company Insights
Innovation and Patenting activity of ABC-MART Inc Q4 2023
GlobalData, the industry analysis specialist, has released its latest company patent databook "Innovation and Patenting activity of ABC-MART Inc Q4 2023". The databook highlights patenting activity of the company in terms of growth in filings and grants, regions protected, impact of various themes, sector applicability of technologies protected. It provides contextual analysis of technical peers, their strategy, dominance (Grant share) and their recent activities. This is an on-demand databook that will be delivered upon request. The report will be delivered...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – TGI-2 in Metastatic Melanoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - TGI-2 in Metastatic Melanoma report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. TGI-2 in Metastatic Melanoma Drug Details: TGI-2 (NM1F) is under development...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – TGI-2 in Solid Tumor
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - TGI-2 in Solid Tumor report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. TGI-2 in Solid Tumor Drug Details: TGI-2 (NM1F) is under development...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – TGI-2 in Metastatic Colorectal Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - TGI-2 in Metastatic Colorectal Cancer report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. TGI-2 in Metastatic Colorectal Cancer Drug Details: TGI-2 (NM1F) is...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – TGI-2 in Metastatic Ovarian Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - TGI-2 in Metastatic Ovarian Cancer report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. TGI-2 in Metastatic Ovarian Cancer Drug Details: TGI-2 (NM1F) is...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – TGI-2 in Triple-Negative Breast Cancer (TNBC)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - TGI-2 in Triple-Negative Breast Cancer (TNBC) report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. TGI-2 in Triple-Negative Breast Cancer (TNBC) Drug Details: TGI-2...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – (DTRMWXHS-12 + Everolimus + Pomalidomide) in Diffuse Large B-Cell Lymphoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - (DTRMWXHS-12 + Everolimus + Pomalidomide) in Diffuse Large B-Cell Lymphoma report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. (DTRMWXHS-12 + Everolimus + Pomalidomide) in...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – (DTRMWXHS-12 + Everolimus + Pomalidomide) in Follicular Lymphoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - (DTRMWXHS-12 + Everolimus + Pomalidomide) in Follicular Lymphoma report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. (DTRMWXHS-12 + Everolimus + Pomalidomide) in Follicular Lymphoma...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – ABC-008 in T-Cell Leukemia
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - ABC-008 in T-Cell Leukemia report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.ABC-008 in T-Cell LeukemiaDrug Details:AB-008 is under development for the treatment of inclusion...